Latest Abraxane Stories
BOTHELL, Wash. and VANCOUVER, British Columbia, Dec. 16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
- ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November MELBOURNE, Australia, Oct.
Urges provinces to move quickly to fund first new treatment for pancreatic cancer approved in Canada in 20 years HALIFAX, Sept.
High unmet need addressed with first new approved treatment in eighteen years MISSISSAUGA, ON, August 6, 2014 /CNW/ - Health Canada has approved (Pr)ABRAXANE(®)
AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company
LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, March 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical
SAN DIEGO, March 6, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
- In medieval musical notation, a sign or neume denoting a shake or trill.